Detection of breast cancer cells specially and accurately by an electrochemical method

被引:128
作者
Li, Ting [3 ]
Fan, Qi [3 ]
Liu, Tao [1 ,2 ]
Zhu, Xiaoli [3 ]
Zhao, Jing [1 ,2 ,3 ]
Li, Genxi [1 ,2 ,3 ]
机构
[1] Nanjing Univ, Dept Biochem, Nanjing 210093, Peoples R China
[2] Nanjing Univ, Natl Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
[3] Shanghai Univ, Sch Life Sci, Lab Biosensing Technol, Shanghai 200444, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer cells; Tumor markers; Electrochemistry; Nanoparticles; CARCINOEMBRYONIC ANTIGEN; TUMOR-MARKERS; BLOOD; MUC1; CARCINOMA; CEA;
D O I
10.1016/j.bios.2010.05.004
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Breast cancer is one of the most common cancers to cause death in the world, and the accurate diagnosis is of great importance to determine the stage of the disease and then to design the suitable therapy. Compared with the traditional detection methods relying on the recognition of only one tumor marker, we herein propose a sensitive electrochemical immunoassay to detect breast cancer cells by simultaneously measuring two co-expressing tumor markers, human mucin-1 and carcinoembryonic antigen on the surface of the cancer cells, which may efficiently improve the accuracy of the detection as well as facilitate the classification of the cancer cells. The experimental results have revealed that well electrochemical response can be observed only under the condition that both of the tumor markers are identified on the surface of the tumor cells. With this method, breast cancer cell MCF-7 can be easily distinguished from other kinds of cells, such as acute leukemia cells CCRF-CEM and normal cells islet beta cells. Moreover, the prepared cytosensor can specially monitor breast cancer cell MCF-7 in a wide range from 104 to 10(7) cell mL(-1) with well reproduction and low detection limit, which may have great potential in clinical applications. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:2686 / 2689
页数:4
相关论文
共 19 条
[1]   Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer.: Comparison of CK19, MUC1 and CEA using RT-PCR [J].
Berois, N ;
Varangot, M ;
Aizen, B ;
Estrugo, R ;
Zarantonelli, L ;
Fernández, P ;
Krygier, G ;
Simonet, F ;
Barrios, E ;
Musé, L ;
Osinaga, E .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (06) :717-723
[2]   Tumour marker measurements in the diagnosis and monitoring of breast cancer [J].
Cheung, KL ;
Graves, CRL ;
Robertson, JFR .
CANCER TREATMENT REVIEWS, 2000, 26 (02) :91-102
[3]   A new immunosensor for breast cancer cell detection using antibody-coated long alkylsilane self-assembled monolayers in a parallel plate flow chamber [J].
Ehrhart, Jean-Claude ;
Bennetau, Bernard ;
Renaud, Louis ;
Madrange, Jean-Pierre ;
Thomas, Laurent ;
Morisot, Julie ;
Brosseau, Arnaud ;
Allano, Sylvain ;
Tauc, Patrick ;
Tran, Phuong-Lan .
BIOSENSORS & BIOELECTRONICS, 2008, 24 (03) :467-474
[4]  
HAAGENSEN DE, 1978, CANCER, V42, P1512, DOI 10.1002/1097-0142(197809)42:3+<1512::AID-CNCR2820420824>3.0.CO
[5]  
2-6
[6]   An electrochemical investigation of glucose oxidase at a CdS nanoparticles modified electrode [J].
Huang, YX ;
Zhang, WJ ;
Xiao, H ;
Li, GX .
BIOSENSORS & BIOELECTRONICS, 2005, 21 (05) :817-821
[7]   Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients [J].
Jezersek, B ;
Cervek, J ;
Rudolf, Z ;
Novakovic, S .
CANCER LETTERS, 1996, 110 (1-2) :137-144
[8]  
Kämmerer U, 2003, ANTICANCER RES, V23, P1051
[9]  
Koepke JA, 2006, CANCER, V69, P1578
[10]   Significance, detection and markers of disseminated breast cancer cells [J].
Lacroix, Marc .
ENDOCRINE-RELATED CANCER, 2006, 13 (04) :1033-1067